A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial

NCT02057380 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: linsitinib
DRUG: erlotinib
DRUG: paclitaxel
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

Astellas Pharma Global Development, Inc.